- Home
- BBIO vs MTCH Comparison
BBIO vs MTCH Comparison
Compare BBIO & MTCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- MTCH
- Stock Information
- Founded
- BBIO 2015
- MTCH 1986
- Country
- BBIO United States
- MTCH United States
- Employees
- BBIO N/A
- MTCH N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- MTCH Computer Software: Programming Data Processing
- Sector
- BBIO Health Care
- MTCH Technology
- Exchange
- BBIO Nasdaq
- MTCH Nasdaq
- Market Cap
- BBIO 6.7B
- MTCH 7.9B
- IPO Year
- BBIO 2019
- MTCH 2015
- Fundamental
- Price
- BBIO $33.02
- MTCH $31.41
- Analyst Decision
- BBIO Strong Buy
- MTCH Buy
- Analyst Count
- BBIO 12
- MTCH 20
- Target Price
- BBIO $52.64
- MTCH $37.84
- AVG Volume (30 Days)
- BBIO 2.7M
- MTCH 4.7M
- Earning Date
- BBIO 05-01-2025
- MTCH 05-06-2025
- Dividend Yield
- BBIO N/A
- MTCH 1.21%
- EPS Growth
- BBIO N/A
- MTCH N/A
- EPS
- BBIO N/A
- MTCH 2.02
- Revenue
- BBIO $221,902,000.00
- MTCH $3,479,373,000.00
- Revenue This Year
- BBIO $12.42
- MTCH $1.05
- Revenue Next Year
- BBIO $123.19
- MTCH $5.23
- P/E Ratio
- BBIO N/A
- MTCH $15.55
- Revenue Growth
- BBIO 2285.27
- MTCH 3.41
- 52 Week Low
- BBIO $21.62
- MTCH $27.66
- 52 Week High
- BBIO $39.47
- MTCH $38.84
- Technical
- Relative Strength Index (RSI)
- BBIO 45.09
- MTCH 48.25
- Support Level
- BBIO $35.77
- MTCH $30.13
- Resistance Level
- BBIO $37.06
- MTCH $32.28
- Average True Range (ATR)
- BBIO 1.46
- MTCH 0.87
- MACD
- BBIO -0.01
- MTCH 0.10
- Stochastic Oscillator
- BBIO 23.60
- MTCH 60.95
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.